简体中文
繁體中文
English
Pусский
日本語
ภาษาไทย
Tiếng Việt
Bahasa Indonesia
Español
हिन्दी
Filippiiniläinen
Français
Deutsch
Português
Türkçe
한국어
العربية
Abstract:WASHINGTON (Reuters) – Abbott Laboratories and the U.S. Food and Drug Administration are on track to reopen the companys Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said on Thursday.
div classBodysc17zpet90 cdBBJodivpWASHINGTON Reuters – Abbott Laboratories and the U.S. Food and Drug Administration are on track to reopen the companys Sturgis, Michigan, baby formula manufacturing plant within one or two weeks, FDA Commissioner Robert Califf said on Thursday.p
p“I think we are on track to get it open within the next week to two weeks, most likely at the outer bound two weeks,” Califf told lawmakers at a U.S. House of Representatives Appropriations Subcommittee hearing.pdivdivdiv classBodysc17zpet90 cdBBJodiv
pThe FDA cannot conclude whether cases of ill babies are directly related to the Abbott plant until its investigation is concluded, Califf said.p
p
pp Reporting by Susan Heavey and Ahmed Aboulenein, Editing by Franklin Paulp
divdivdiv classBodysc17zpet90 cdBBJodivdivdiv
Disclaimer:
The views in this article only represent the author's personal views, and do not constitute investment advice on this platform. This platform does not guarantee the accuracy, completeness and timeliness of the information in the article, and will not be liable for any loss caused by the use of or reliance on the information in the article.